CompletedPhase 2NCT04059770
Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alessandro Pasqualotto
- Principal Investigator
- Daiane Dalla Lana, PhDFederal University of Health Science of Porto Alegre
- Intervention
- single dose of L-AmB(drug)
- Enrollment
- 118 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2022
Study locations (1)
- Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Collaborators
Hospital de Clinicas de Porto Alegre · Hospital Nossa Senhora da Conceicao · Irmandade Santa Casa de Misericórdia de Porto Alegre
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04059770 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.